|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Impairment loss | |||||
| Depreciation and amortization expense | |||||
| Gain on settlement of lease liabilities | |||||
| Loss on extinguishment of long term debt | |||||
| Changes in fair value of interest rate swap | |||||
| Changes in fair value of contingent earn-out liability | |||||
| Non-cash lease expense | |||||
| Tax receivable agreement liability remeasurement expense | |||||
| Deferred income tax | |||||
| Stock-based compensation expense | |||||
| Net foreign exchange difference | |||||
| Other, net | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Deferred revenue | |||||
| Legal liabilities | |||||
| Lease liabilities | |||||
| Accrued expenses and other current liabilities | |||||
| Other, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Acquisition of business, net of cash acquired | |||||
| Other, net | |||||
| Acquisition of intangible assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of Class A common stock sold in initial public offering, net of offering costs | |||||
| Repayment of term loan | |||||
| Debt issuance costs | |||||
| Distributions paid to noncontrolling interest holders | |||||
| Share repurchases | |||||
| Purchase of Common Units from Pre-IPO Common Unitholders in the initial public offering | |||||
| Proceeds from exercise of options | |||||
| Purchase of Common Units | |||||
| Withholding tax paid on behalf of employees on stock-based awards | |||||
| Payments on tax receivable agreement | |||||
| Net cash used in financing activities | |||||
| Effects of exchange rate changes on cash and cash equivalents | |||||
| Net decrease in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of the period | |||||
| Cash and cash equivalents and restricted cash, end of the period | |||||
| Less restricted cash | |||||
| Cash and cash equivalents, end of the period | |||||
Loading...